Functional implications of novel human acid sphingomyelinase splice variants.

<h4>Background</h4>Acid sphingomyelinase (ASM) hydrolyses sphingomyelin and generates the lipid messenger ceramide, which mediates a variety of stress-related cellular processes. The pathological effects of dysregulated ASM activity are evident in several human diseases and indicate an i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cosima Rhein, Philipp Tripal, Angela Seebahn, Alice Konrad, Marcel Kramer, Christine Nagel, Jonas Kemper, Jens Bode, Christiane Mühle, Erich Gulbins, Martin Reichel, Cord-Michael Becker, Johannes Kornhuber
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d93747c8225746268ebeac7480e22c92
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d93747c8225746268ebeac7480e22c92
record_format dspace
spelling oai:doaj.org-article:d93747c8225746268ebeac7480e22c922021-11-18T07:20:35ZFunctional implications of novel human acid sphingomyelinase splice variants.1932-620310.1371/journal.pone.0035467https://doaj.org/article/d93747c8225746268ebeac7480e22c922012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22558155/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Acid sphingomyelinase (ASM) hydrolyses sphingomyelin and generates the lipid messenger ceramide, which mediates a variety of stress-related cellular processes. The pathological effects of dysregulated ASM activity are evident in several human diseases and indicate an important functional role for ASM regulation. We investigated alternative splicing as a possible mechanism for regulating cellular ASM activity.<h4>Methodology/principal findings</h4>We identified three novel ASM splice variants in human cells, termed ASM-5, -6 and -7, which lack portions of the catalytic- and/or carboxy-terminal domains in comparison to full-length ASM-1. Differential expression patterns in primary blood cells indicated that ASM splicing might be subject to regulatory processes. The newly identified ASM splice variants were catalytically inactive in biochemical in vitro assays, but they decreased the relative cellular ceramide content in overexpression studies and exerted a dominant-negative effect on ASM activity in physiological cell models.<h4>Conclusions/significance</h4>These findings indicate that alternative splicing of ASM is of functional significance for the cellular stress response, possibly representing a mechanism for maintaining constant levels of cellular ASM enzyme activity.Cosima RheinPhilipp TripalAngela SeebahnAlice KonradMarcel KramerChristine NagelJonas KemperJens BodeChristiane MühleErich GulbinsMartin ReichelCord-Michael BeckerJohannes KornhuberPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 4, p e35467 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Cosima Rhein
Philipp Tripal
Angela Seebahn
Alice Konrad
Marcel Kramer
Christine Nagel
Jonas Kemper
Jens Bode
Christiane Mühle
Erich Gulbins
Martin Reichel
Cord-Michael Becker
Johannes Kornhuber
Functional implications of novel human acid sphingomyelinase splice variants.
description <h4>Background</h4>Acid sphingomyelinase (ASM) hydrolyses sphingomyelin and generates the lipid messenger ceramide, which mediates a variety of stress-related cellular processes. The pathological effects of dysregulated ASM activity are evident in several human diseases and indicate an important functional role for ASM regulation. We investigated alternative splicing as a possible mechanism for regulating cellular ASM activity.<h4>Methodology/principal findings</h4>We identified three novel ASM splice variants in human cells, termed ASM-5, -6 and -7, which lack portions of the catalytic- and/or carboxy-terminal domains in comparison to full-length ASM-1. Differential expression patterns in primary blood cells indicated that ASM splicing might be subject to regulatory processes. The newly identified ASM splice variants were catalytically inactive in biochemical in vitro assays, but they decreased the relative cellular ceramide content in overexpression studies and exerted a dominant-negative effect on ASM activity in physiological cell models.<h4>Conclusions/significance</h4>These findings indicate that alternative splicing of ASM is of functional significance for the cellular stress response, possibly representing a mechanism for maintaining constant levels of cellular ASM enzyme activity.
format article
author Cosima Rhein
Philipp Tripal
Angela Seebahn
Alice Konrad
Marcel Kramer
Christine Nagel
Jonas Kemper
Jens Bode
Christiane Mühle
Erich Gulbins
Martin Reichel
Cord-Michael Becker
Johannes Kornhuber
author_facet Cosima Rhein
Philipp Tripal
Angela Seebahn
Alice Konrad
Marcel Kramer
Christine Nagel
Jonas Kemper
Jens Bode
Christiane Mühle
Erich Gulbins
Martin Reichel
Cord-Michael Becker
Johannes Kornhuber
author_sort Cosima Rhein
title Functional implications of novel human acid sphingomyelinase splice variants.
title_short Functional implications of novel human acid sphingomyelinase splice variants.
title_full Functional implications of novel human acid sphingomyelinase splice variants.
title_fullStr Functional implications of novel human acid sphingomyelinase splice variants.
title_full_unstemmed Functional implications of novel human acid sphingomyelinase splice variants.
title_sort functional implications of novel human acid sphingomyelinase splice variants.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/d93747c8225746268ebeac7480e22c92
work_keys_str_mv AT cosimarhein functionalimplicationsofnovelhumanacidsphingomyelinasesplicevariants
AT philipptripal functionalimplicationsofnovelhumanacidsphingomyelinasesplicevariants
AT angelaseebahn functionalimplicationsofnovelhumanacidsphingomyelinasesplicevariants
AT alicekonrad functionalimplicationsofnovelhumanacidsphingomyelinasesplicevariants
AT marcelkramer functionalimplicationsofnovelhumanacidsphingomyelinasesplicevariants
AT christinenagel functionalimplicationsofnovelhumanacidsphingomyelinasesplicevariants
AT jonaskemper functionalimplicationsofnovelhumanacidsphingomyelinasesplicevariants
AT jensbode functionalimplicationsofnovelhumanacidsphingomyelinasesplicevariants
AT christianemuhle functionalimplicationsofnovelhumanacidsphingomyelinasesplicevariants
AT erichgulbins functionalimplicationsofnovelhumanacidsphingomyelinasesplicevariants
AT martinreichel functionalimplicationsofnovelhumanacidsphingomyelinasesplicevariants
AT cordmichaelbecker functionalimplicationsofnovelhumanacidsphingomyelinasesplicevariants
AT johanneskornhuber functionalimplicationsofnovelhumanacidsphingomyelinasesplicevariants
_version_ 1718423630786854912